Jean D. Wilson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jean D. Wilson has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Geoffrey Shaw
The University of Melbourne
8 shared publications - Marilyn Bernice Renfree
School of BioSciences, The University of Melbourne, Melbourne, VIC, Australia
8 shared publications Michael W. Leihy
ADepartment of Zoology, University of Melbourne, Victoria 3010, Australia
4 shared publicationsRichard J. Auchus
BDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-8857, USA
3 shared publications- Andrew J. Pask
School of BioSciences, The University of Melbourne, Victoria, Australia
1 shared publication Cedric H. L. Shackleton
Department of Zoology, University of Melbourne, Victoria 3010, Australia; †Children's Hospital Oakland Research Institute, 5700 Martin Luther King, Jr. Way, Oakland, CA 94609-1673; and ‡Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8857
1 shared publication
Latest Publications
- 21 May 2009
- Published by CSIRO Publishing in Reproduction, Fertility and Development
- Vol. 21 (5) , 649-654
Formation of 5a-reduced androgens in the testes and urogenital tract of the grey short-tailed opossum, Monodelphis domestica
Testicular 5a-reduced androgens, largely 5a-androstane-3a,17ß-diol (androstanediol), are responsible for virilisation of pouch young in one marsupial (the tammar wallaby), but are not formed until later in development in another marsupial (the brushtail possum) and in rodents. Because the mechanism of virilisation of the urogenital tract in the grey short-tailed opossum Monodelphis domestica has never been defined, androgen formation and metabolism were investigated in this species. Testis fragments from grey short-tailed opossums of a wide range of ages were incubated with [3H]-progesterone and the metabolites were separated by high-performance liquid chromatography (HPLC). The only 19-carbon metabolites identified in the youngest ages (5–26 days) and the major metabolites in adult testes were testosterone and androstenedione. At 30, 42 and 49 days of age, dihydrotestosterone and small amounts of androstanediol were present. Time-sequence studies indicated that dihydrotestosterone and androstanediol were formed from the 5a-reduction (and 3-keto reduction) of testosterone. In a second series of experiments, tissue fragments of a variety of urogenital tract tissues were incubated with [3H]-testosterone and the metabolites separated by HPLC. During the interval in which male urogenital tract differentiation takes place in this species (between Days 15 and 28), the major metabolite identified was dihydrotestosterone. We conclude that the timing of 5a-reductase expression in the testes of the grey short-tailed possum resembles that of rodents and the brushtail possum rather than that of the tammar wallaby and that dihydrotestosterone is probably the intracellular androgen responsible for virilisation of the urogenital tract in this species.
- 21 May 2009
- Published by CSIRO Publishing in Reproduction, Fertility and Development
- Vol. 21 (5) , 649-654
Formation of 5a-reduced androgens in the testes and urogenital tract of the grey short-tailed opossum, Monodelphis domestica
Testicular 5a-reduced androgens, largely 5a-androstane-3a,17ß-diol (androstanediol), are responsible for virilisation of pouch young in one marsupial (the tammar wallaby), but are not formed until later in development in another marsupial (the brushtail possum) and in rodents. Because the mechanism of virilisation of the urogenital tract in the grey short-tailed opossum Monodelphis domestica has never been defined, androgen formation and metabolism were investigated in this species. Testis fragments from grey short-tailed opossums of a wide range of ages were incubated with [3H]-progesterone and the metabolites were separated by high-performance liquid chromatography (HPLC). The only 19-carbon metabolites identified in the youngest ages (5–26 days) and the major metabolites in adult testes were testosterone and androstenedione. At 30, 42 and 49 days of age, dihydrotestosterone and small amounts of androstanediol were present. Time-sequence studies indicated that dihydrotestosterone and androstanediol were formed from the 5a-reduction (and 3-keto reduction) of testosterone. In a second series of experiments, tissue fragments of a variety of urogenital tract tissues were incubated with [3H]-testosterone and the metabolites separated by HPLC. During the interval in which male urogenital tract differentiation takes place in this species (between Days 15 and 28), the major metabolite identified was dihydrotestosterone. We conclude that the timing of 5a-reductase expression in the testes of the grey short-tailed possum resembles that of rodents and the brushtail possum rather than that of the tammar wallaby and that dihydrotestosterone is probably the intracellular androgen responsible for virilisation of the urogenital tract in this species.
- 17 June 2005
- Published by CSIRO Publishing in Reproduction, Fertility and Development
- Vol. 17 (6) , 603-609
Ontogeny and pathway of formation of 5a-androstane-3a,17ß-diol in the testes of the immature brushtail possum Trichosurus vulpecula
The testicular androgen 5a-androstane-3a,17ß-diol (androstanediol) mediates virilisation in pouch young of a marsupial, the tammar wallaby, and is the principal androgen formed in immature rodent testes. To chart the pattern of androstanediol formation in another marsupial species, the testes or fragments of testes from brushtail possums (Trichosurus vulpecula) that spanned the age range from early pouch young to mature adults were incubated with 3H-progesterone and the products were identified by high-performance liquid chromatography. The only 19-carbon steroids identified in pouch young and adult testes were the ?4-3-keto-steroids testosterone and androstenedione. However, androstanediol and another 5a-reduced androgen (androsterone) were synthesised by testes from Day 87–200 males and these appeared to be formed from the 5a-reduction and 3-keto reduction of testosterone and androstenedione. In the prostate and glans penis of the immature male, 3H-androstanediol was converted to dihydrotestosterone. We conclude that the timing of androstanediol formation in the possum testis resembles the process in rodents rather than in the tammar wallaby and that any androstanediol in the circulation probably acts in target tissues via conversion to dihydrotestosterone.
- 17 June 2005
- Published by CSIRO Publishing in Reproduction, Fertility and Development
- Vol. 17 (6) , 603-609
Ontogeny and pathway of formation of 5a-androstane-3a,17ß-diol in the testes of the immature brushtail possum Trichosurus vulpecula
The testicular androgen 5a-androstane-3a,17ß-diol (androstanediol) mediates virilisation in pouch young of a marsupial, the tammar wallaby, and is the principal androgen formed in immature rodent testes. To chart the pattern of androstanediol formation in another marsupial species, the testes or fragments of testes from brushtail possums (Trichosurus vulpecula) that spanned the age range from early pouch young to mature adults were incubated with 3H-progesterone and the products were identified by high-performance liquid chromatography. The only 19-carbon steroids identified in pouch young and adult testes were the ?4-3-keto-steroids testosterone and androstenedione. However, androstanediol and another 5a-reduced androgen (androsterone) were synthesised by testes from Day 87–200 males and these appeared to be formed from the 5a-reduction and 3-keto reduction of testosterone and androstenedione. In the prostate and glans penis of the immature male, 3H-androstanediol was converted to dihydrotestosterone. We conclude that the timing of androstanediol formation in the possum testis resembles the process in rodents rather than in the tammar wallaby and that any androstanediol in the circulation probably acts in target tissues via conversion to dihydrotestosterone.
- 11 March 2005
- Published by Wiley in Clinical Endocrinology
- Vol. 62 (4) , 389-396
The evolution of endocrinology
- 11 March 2005
- Published by Wiley in Clinical Endocrinology
- Vol. 62 (4) , 389-396
The evolution of endocrinology
- 13 November 2003
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 211 (1-2) , 33-36
Unsolved problems in male physiology: studies in a marsupial
- 13 November 2003
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 211 (1-2) , 33-36
Unsolved problems in male physiology: studies in a marsupial
- 1 March 2003
- Published by Annual Reviews in Annual Review of Physiology
- Vol. 65 (1) , 1-21
A Double Life: Academic Physician and Androgen Physiologist
▪ Abstract My work in physiology was designed to investigate the process of androgen action within target cells and to use this information to provide insight into the clinical disorders of androgen action. The discovery that the circulating male androgen testosterone is 5α-reduced to a more potent hormone, dihydrotestosterone, in target tissues and that dihydrotestosterone and testosterone work by binding to the same androgen receptor protein has provided insight into the inherited syndromes of androgen resistance that impair the formation of the male urogenital tract during embryogenesis and into the role of continued dihydrotestosterone formation in the pathogenesis of prostatic hyperplasia in dogs and men.
- 1 March 2003
- Published by Annual Reviews in Annual Review of Physiology
- Vol. 65 (1) , 1-21
A Double Life: Academic Physician and Androgen Physiologist
▪ Abstract My work in physiology was designed to investigate the process of androgen action within target cells and to use this information to provide insight into the clinical disorders of androgen action. The discovery that the circulating male androgen testosterone is 5α-reduced to a more potent hormone, dihydrotestosterone, in target tissues and that dihydrotestosterone and testosterone work by binding to the same androgen receptor protein has provided insight into the inherited syndromes of androgen resistance that impair the formation of the male urogenital tract during embryogenesis and into the role of continued dihydrotestosterone formation in the pathogenesis of prostatic hyperplasia in dogs and men.
- 1 February 2003
- Published by The Endocrine Society in Endocrinology
- Vol. 144 (2) , 575-580
5α-Androstane-3α,17β-Diol Is Formed in Tammar Wallaby Pouch Young Testes by a Pathway Involving 5α-Pregnane-3α,17α-Diol-20-One as a Key Intermediate
The synthetic pathway by which 5α-androstane-3α,17β-diol (5α-adiol) is formed in the testes of tammar wallaby pouch young was investigated by incubating testes from d 20–40 males with various radioactive precursors and analyzing the metabolites by thin-layer chromatography and HPLC. [3H]Progesterone was converted to 17-hydroxyprogesterone, which was converted to 5α-adiol by two pathways: One involves the formation of testosterone and dihydrotestosterone as intermediates, and the other involves formation of 5α-pregnane-3α,17α-diol-20-one (5α-pdiol) and androsterone as intermediates. Formation of 5α-adiol from both [3H]testosterone and [3H]progesterone was blocked by the 5α-reductase inhibitor 4MA. The addition of nonradioactive 5α-pdiol blocked the conversion of [3H]progesterone to 5α-adiol, and [3H]5α-pdiol was efficiently converted to androsterone and 5α-adiol. We conclude that expression of steroid 5α-reductase in the developing wallaby testes allows formation of 5α-reduced androgens by a pathway that does not involve testosterone as an intermediate.
- 1 February 2003
- Published by The Endocrine Society in Endocrinology
- Vol. 144 (2) , 575-580
5α-Androstane-3α,17β-Diol Is Formed in Tammar Wallaby Pouch Young Testes by a Pathway Involving 5α-Pregnane-3α,17α-Diol-20-One as a Key Intermediate
The synthetic pathway by which 5α-androstane-3α,17β-diol (5α-adiol) is formed in the testes of tammar wallaby pouch young was investigated by incubating testes from d 20–40 males with various radioactive precursors and analyzing the metabolites by thin-layer chromatography and HPLC. [3H]Progesterone was converted to 17-hydroxyprogesterone, which was converted to 5α-adiol by two pathways: One involves the formation of testosterone and dihydrotestosterone as intermediates, and the other involves formation of 5α-pregnane-3α,17α-diol-20-one (5α-pdiol) and androsterone as intermediates. Formation of 5α-adiol from both [3H]testosterone and [3H]progesterone was blocked by the 5α-reductase inhibitor 4MA. The addition of nonradioactive 5α-pdiol blocked the conversion of [3H]progesterone to 5α-adiol, and [3H]5α-pdiol was efficiently converted to androsterone and 5α-adiol. We conclude that expression of steroid 5α-reductase in the developing wallaby testes allows formation of 5α-reduced androgens by a pathway that does not involve testosterone as an intermediate.
- 1 December 2002
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 198 (1-2) , 1-5
Androgen physiology: unsolved problems at the millennium
- 1 December 2002
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 198 (1-2) , 1-5
Androgen physiology: unsolved problems at the millennium
- 1 March 2002
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 13 (2) , 78-83
The marsupial model for male phenotypic development
- 1 March 2002
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 13 (2) , 78-83
The marsupial model for male phenotypic development
- Open Access
- 7 February 2001
- Published by American Medical Association (AMA) in JAMA
- Vol. 285 (5) , 624-627
Prospects for Research for Disorders of the Endocrine System
Endocrine disorders, primarily diseases of the thyroid, parathyroids, pituitary, gonad, and adrenal glands, constitute a major health problem in all societies. As a result of improved insight into the diagnosis, pathophysiology, and molecular bases, it is now possible to diagnose the disorders earlier in their development, and the treatment of the deficiency states for most hormones is successful. Furthermore, with recognition that many of these disorders are either the consequence of single-gene mutations or have a major genetic component, it is now possible to diagnose affected fetuses and family members at risk. Therapies for the syndromes of hormone overproduction are less successful and frequently result in destruction of the endocrine organ involved, and the treatment of hormone resistance states is similarly unsatisfactory. These disorders are candidates for the development of superagonists/antagonists and gene therapies.
- 7 February 2001
- Published by American Medical Association (AMA) in JAMA
- Vol. 285 (5) , 624-627
Open AccessProspects for Research for Disorders of the Endocrine System
Endocrine disorders, primarily diseases of the thyroid, parathyroids, pituitary, gonad, and adrenal glands, constitute a major health problem in all societies. As a result of improved insight into the diagnosis, pathophysiology, and molecular bases, it is now possible to diagnose the disorders earlier in their development, and the treatment of the deficiency states for most hormones is successful. Furthermore, with recognition that many of these disorders are either the consequence of single-gene mutations or have a major genetic component, it is now possible to diagnose affected fetuses and family members at risk. Therapies for the syndromes of hormone overproduction are less successful and frequently result in destruction of the endocrine organ involved, and the treatment of hormone resistance states is similarly unsatisfactory. These disorders are candidates for the development of superagonists/antagonists and gene therapies.
- 1 January 2001
- Published by CSIRO Publishing in Reproduction, Fertility and Development
- Vol. 13 (8) , 673-8
The role of 5a-reduction in steroid hormone physiology
A role for 5α-reduction in androgen physiology was first established with the recognition that dihydrotestosterone, the 5α-reduced metabolite of testosterone, is formed in many androgen target tissues, binds to the androgen receptor with greater affinity than testosterone, and plays an essential role in virilization of the urogenital sinus and urogenital tubercle during male development. Two 5α-reductases perform this reaction, and both isoenzymes utilize NADPH as cofactor and have broad specificity for steroids containing a Δ4, 3-keto configuration. 5α-Reduction, which is essentially irreversible, flattens the steroid molecule because of altered relation of the A and B rings, and stabilizes the hormone–receptor complex. Studies involving in vitro reporter gene assays and intact mice in which both isoenzymes are disrupted, indicate that the fundamental effect of dihydrotestosterone formation is to amplify hormonal signals that can be mediated by testosterone at higher concentrations. 5α-Reduction also plays a role in the action of other steroid hormones, including the plant growth hormone, brassinolide, the boar pheromones, androstanol and androstenol, progesterone (in some species), and, possibly, aldosterone and cortisol. The fact that the reaction is important in plants and animals implies a fundamental role in steroid hormone action.
- 1 January 2001
- Published by CSIRO Publishing in Reproduction, Fertility and Development
- Vol. 13 (8) , 673-8
The role of 5a-reduction in steroid hormone physiology
A role for 5α-reduction in androgen physiology was first established with the recognition that dihydrotestosterone, the 5α-reduced metabolite of testosterone, is formed in many androgen target tissues, binds to the androgen receptor with greater affinity than testosterone, and plays an essential role in virilization of the urogenital sinus and urogenital tubercle during male development. Two 5α-reductases perform this reaction, and both isoenzymes utilize NADPH as cofactor and have broad specificity for steroids containing a Δ4, 3-keto configuration. 5α-Reduction, which is essentially irreversible, flattens the steroid molecule because of altered relation of the A and B rings, and stabilizes the hormone–receptor complex. Studies involving in vitro reporter gene assays and intact mice in which both isoenzymes are disrupted, indicate that the fundamental effect of dihydrotestosterone formation is to amplify hormonal signals that can be mediated by testosterone at higher concentrations. 5α-Reduction also plays a role in the action of other steroid hormones, including the plant growth hormone, brassinolide, the boar pheromones, androstanol and androstenol, progesterone (in some species), and, possibly, aldosterone and cortisol. The fact that the reaction is important in plants and animals implies a fundamental role in steroid hormone action.